IP & Open Innovation Decision Tree

Purpose

This tool helps teams make timely, strategically aligned decisions about protecting or sharing an invention so research, publications, partnerships, and commercialization stay on track. Use the questions and checklist below to evaluate options (patent, defensive publication, open sharing, hybrid models, or partnership-first strategies) and turn a decision into concrete next steps.

How to use this decision tree

Read each decision node and answer honestly. The guidance after each node recommends practical actions, who to involve, and what to document. Keep a short record of your decision and the reasons — that record is valuable for later choices, funding, and collaborations.

Decision nodes and recommended actions

1. Novelty & inventiveness

   Is the idea new and non‑obvious compared with public prior art?

   If yes: proceed to commercial potential. If unsure: conduct a quick prior‑art or literature search and document findings; talk with a patent professional or tech transfer office.

2. Commercial potential & strategic value

   Does the invention have plausible commercial value, licensing potential, or strategic importance for the organization?

   If yes: patenting is worth considering. If no but the idea advances science or community goals, consider open sharing or a defensive publication.

3. Publication & timing constraints

   Are you planning to publish, present, or disclose publicly soon?

   If yes: file a provisional application or an invention disclosure (or arrange an embargo) before public disclosure; otherwise you may lose patent rights in many jurisdictions. If immediate filing is not possible, consider a defensive publication to preserve freedom to operate for others while preventing patents by competitors.

4. Funder, collaborator, or institutional obligations

   Do funders, sponsors, or institutional policies require or limit IP claims?

   If yes: review agreements; follow funder/institution rules; involve tech transfer and legal counsel to align obligations with strategy.

5. Partnership & commercialization readiness

   Is the team ready to engage partners or licensees? Are there resources or a business case to develop the IP?

   If ready: coordinate joint IP agreements, NDAs, and terms with partners early. If not: consider open or hybrid approaches that allow collaborative development while preserving core rights (e.g., patent key claims, open others).

6. Risk of blocking collaboration

   Would aggressive IP protection block essential future collaborations, downstream research, or adoption?

   If yes: consider non‑exclusive licensing, open‑access sharing, or time‑limited exclusive arrangements to balance protection and partnership.

Practical decision outcomes — what to do next

• File provisional or disclose to tech transfer — when novelty and commercial potential are clear and a public disclosure is planned. Provisional filings are a low‑cost way to secure a priority date while you develop the invention. (Consult your institution or counsel for jurisdictional details.)
• Prepare invention disclosure — collect dated lab notes, prototypes, data, contributors, and intended claims. Submit this to tech transfer/legal.
• Defensive publication — when commercial value is low but you want to prevent competitors from patenting. A clear, searchable public disclosure can remove novelty.
• Open sharing / Open innovation — when broad uptake, scientific progress, or public benefit outweighs exclusive commercial rights. Choose licenses (e.g., permissive or copyleft) appropriate to goals and downstream use.
• Hybrid approach — patent core enabling features while open‑licensing non‑core methods or datasets to encourage adoption and collaboration.
• Partnership-first strategy — negotiate collaboration agreements, joint ownership, or exclusive development rights with clear milestones before deep disclosure.

Quick checklist — immediate actions

• Stop any public disclosure (if patent is a possibility) until you have filed or consulted with tech transfer.
• Record the invention in dated form (lab notebook, repository, screenshots, datasets) and identify contributors.
• Run a targeted prior‑art search and summarize findings.
• Draft a short invention disclosure (what it does, why new, who did it, evidence, commercialization notes).
• Contact your tech transfer office or an IP attorney with the disclosure and timeline for publication.
• Check funder or sponsor IP clauses and reporting obligations.

Common mistakes to avoid

• Publishing key details before filing or disclosing to tech transfer.
• Assuming all inventions should be patented — sometimes open or defensive strategies have higher net value.
• Delaying engagement with tech transfer until it's too late to preserve rights or prepare collaborations.
• Overly restrictive agreements that block downstream research or partnership opportunities.

Example scenarios

Scenario A — New assay with startup interest: novelty confirmed, commercial potential high, publication planned next month. Recommended: prepare provisional and invention disclosure within days; pause public disclosure until filed; involve tech transfer for commercialization pathway.

Scenario B — Useful analysis script with broad academic value but low licensing potential: consider open licensing (e.g., permissive OSS) and a citable repository; defensive publication usually not necessary.

Where to get help

Contact your institution's tech transfer office, an IP attorney, or your funding program officer. If you have internal commercialization or business development teams, loop them in early for market assessment and partner outreach.

Notes and cautions

This guidance is practical and general. IP laws and deadlines vary by country and circumstance. Always confirm filing deadlines, ownership rules, and funder obligations with legal counsel or your tech transfer office before taking definitive action.

Recommended record: one‑page decision memo (date, authors, brief reasons for chosen path, immediate next steps, contacts).